Proarrhythmic effects of intravenous quinidine, amiodarone, d-sotalol, and almokalant in the anesthetized rabbit model of torsade de pointes

Journal of Cardiovascular Pharmacology

Volumn 39, Issue 2, 2002, Pages 287-297

  Farkas, András ^a   Leprán, István ^a   Papp, Julius Gy ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

1 Adrenoceptor stimulation; Almokalant; Amiodarone; D sotalol; Quinidine; Torsade de pointes

Indexed keywords

ALMOKALANT; AMIODARONE; CHLORALOSE; QUINIDINE; SOTALOL;

ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAPHY; EVOKED RESPONSE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART REPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; TORSADE DES POINTES;

ADRENERGIC ALPHA-AGONISTS; AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; BLOOD PRESSURE; ELECTROCARDIOGRAPHY; HEART RATE; INFUSIONS, INTRAVENOUS; MALE; PHENYLEPHRINE; PROPANOLAMINES; QUINIDINE; RABBITS; RECEPTORS, ADRENERGIC, ALPHA-1; SOTALOL; TORSADES DE POINTES;

EID: 0036150473     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200202000-00016     Document Type: Article

References (47)

1. Torsades de pointes associated with drugs and toxins: Recognition and management
2. Torsade de pointes
3. The potential for QT prolongation and proarrhythmia by nonantiarrhythmic drugs: Clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology
4. More on amiodarone and torsade de pointes
5. Intravenous amiodarone
6. Early proarrhythmia during intravenous amiodarone treatment
7. Torsades de pointes with Almokalant, a new class III antiarrhythmic drug
8. Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextroisomer of sotalol
9. Experimental models of torsades de pointes
10. Animal models of the long QT syndrome: Relation to clinical features
11. Experimental models of torsade de pointes
12. QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: Etiology and interventions
13. Proarrhythmic effects of the class III agent almokalant: Importance of infusion rate, QT dispersion, and early after depolarizations
14. Comparative assessment of ibutilide, D-sotalol, clofilium, E-4031, and UK-68,798 in a rabbit model of proarrhythmia
15. Comparison of the antiarrhythmic and the proarrhythmic effect of almokalant in anesthetized rabbits
16. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: Experimental profile of BRL-32872
17. Potassium and calcium current blocking properties of the novel antiarrhythmic agent H 345/52: Implications for proarrhythmic potential
18. Effects of ring fluorination on the adrenergic properties of phenylephrine
19. Antiarrhythmic and electrophysiological effects of GYKI-16638, a novel N-(phenoxyalkyl)-N-phenylalkylamine, in rabbits
20. Anesthetized rabbit as a model for ischemia- and reperfusion-induced arrhythmias: Effects of quinidine and bretylium
21. The Lambeth Conventions: Guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion
22. Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient care
23. Torsades de pointes and ventricular fibrillation in a canine model of quinidine-induced QT prolongation
24. Proarrhythmic effects of a quinidine analog in dogs with chronic A-V block
25. Nonselective I(Kr)-blockers do not induce torsades de pointes in the anesthetized rabbit during alpha1-adrenoceptor stimulation
26. Effects of quinidine on repolarization in canine epicardium, midmyocardium, and endocardium: I: In vitro study
27. Attenuation of proarrhythmias related to delayed repolarization by low-dose lidocaine in the anesthetized rabbit
28. Anticholinergic action of quinidine sulfate in the rabbit atrioventricular node
29. Quinidine is a competitive antagonist at alpha 1- and alpha 2-adrenergic receptors
30. Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: Implications for proarrhythmic potential?
31. Serum and myocardial kinetics of amiodarone and its deethyl metabolite after intravenous administration in rabbits
32. Electrophysiologic effects of amiodarone: Experimental and clinical observation relative to serum and tissue drug concentrations
33. Cardiac electrophysiologic effects of acute and chronic amiodarone administration in the isolated perfused rabbit heart: Altered thyroid hormone metabolism
34. Comparison of the chronic and acute effects of amiodarone on the calcium and potassium currents in rabbit isolated cardiac myocytes
35. Acute and chronic effects of amiodarone on mammalian ventricular cells
36. Antiarrhythmic actions of amiodarone: A profile of a paradoxical agent
37. Amiodarone-induced block of sodium current in isolated cardiac cells
38. Rhythm anomalies related to delayed repolarization in vivo: Influence of sarcolemmal Ca++ entry and intracellular Ca++ overload
39. The adrenergic antagonism of amiodarone
40. Further observations to elucidate the role of interventricular dispersion of repolarization and early after depolarizations in the genesis of acquired torsade de pointes arrhythmias: A comparison between almokalant and d-sotalol using the dog as its own control
41. Differential effects of the new class III antiarrhythmic agents almokalant, E-4031 and D-sotalol, and of quinidine, on delayed rectifier currents in guinea pig ventricular myocytes
42. Comparative beta-blocking activities and electrophysiologic actions of racemic sotalol and its optical isomers in anesthetized dogs
43. Selectivity of class-III antiarrhythmic action of clofilium in guinea pig ventricular myocytes
44. The min K channel underlies the cardiac potassium current IKs and mediates species-specific responses to protein kinase C
45. Antiarrhythmic drugs, clofilium and cibenzoline are potent inhibitors of glibenclamide-sensitive K+ currents in Xenopus oocytes
46. Selective inhibition of potassium currents in rat ventricle by clofilium and its tertiary homolog
47. Proarrhythmia of azimilide and other class III antiarrhythmic agents in the adrenergically stimulated rabbit